Mycobacterium Tuberculosis Conserved Hypothetical Protein RRv2626c Modulates Macrophage Effector Functions

Overview

Journal Immunology

Specialty Allergy & Immunology

Date 2010 Mar 6

PMID 20201990

Citations 16

Authors

Nasreena Bashir

Fozia Kounsar

Sangita Mukhopadhyay

Seyed E Hasnain

Affiliations

Soon will be listed here.

Abstract

Secretory proteins of Mycobacterium tuberculosis are the major immunomodulators of the host immune response. Open reading frame (ORF) Rv2626c, encoding a conserved hypothetical protein eliciting a strong humoral immune response in patients with tuberculosis (TB), was shown to be up-regulated upon infection in mice under hypoxic conditions. We now show that recombinant Rv2626c protein (rRv2626c) can bind to the surface of murine macrophages and elicit the type-1 immune response, as manifested by nitric oxide (NO) secretion and expression of inducible nitric oxide synthase (iNOS). Significant induction of pro-inflammatory cytokines [interleukin (IL)-12 and tumour necrosis factor (TNF)-alpha] was evident upon stimulation of murine macrophages, as well as peripheral blood mononuclear cells (PBMCs) isolated from patients with active TB disease, with rRv2626c. Stimulation with rRv2626c also enhanced the expression of costimulatory molecules such as B7-1, B7-2 and CD40 on murine macrophages. We further show that the production of NO and pro-inflammatory cytokines in response to rRv2626c is mediated by the transcription factor nuclear factor (NF)-kappaB, and this was further confirmed using pyrrolidine dithiocarbamate (PDTC), a specific pharmacological inhibitor of NF-kappaB. Rv2626c therefore appears to modulate macrophage effector functions by eliciting both innate and adaptive immune responses, suggesting its possible use as a vaccine candidate.

Citing Articles

Tuberculosis vaccines and therapeutic drug: challenges and future directions.

An Y, Ni R, Zhuang L, Yang L, Ye Z, Li L Mol Biomed. 2025; 6(1):4.

PMID: 39841361 PMC: 11754781. DOI: 10.1186/s43556-024-00243-6.

Gene Regulatory Mechanism of Mycobacterium Tuberculosis during Dormancy.

Liu Y, Li H, Dai D, He J, Liang Z Curr Issues Mol Biol. 2024; 46(6):5825-5844.

PMID: 38921019 PMC: 11203133. DOI: 10.3390/cimb46060348.

The Landscape and Perspectives of the Human Gut Metaproteomics.

Sun Z, Ning Z, Figeys D Mol Cell Proteomics. 2024; 23(5):100763.

PMID: 38608842 PMC: 11098955. DOI: 10.1016/j.mcpro.2024.100763.

Turning a pathogen protein into a therapeutic tool for sepsis.

Vanderhaeghen T, Wallaeys C, Libert C EMBO Mol Med. 2020; 13(1):e13589.

PMID: 33332738 PMC: 7799353. DOI: 10.15252/emmm.202013589.

Mycobacterium tuberculosis Rv2626c-derived peptide as a therapeutic agent for sepsis.

Kim S, Kim D, Kim S, Lee D, Mun S, Cho E EMBO Mol Med. 2020; 12(12):e12497.

PMID: 33258196 PMC: 7721357. DOI: 10.15252/emmm.202012497.

References

Al-Attiyah R, Mustafa A, Abal A, El-Shamy A, Dalemans W, Skeiky Y . In vitro cellular immune responses to complex and newly defined recombinant antigens of Mycobacterium tuberculosis. Clin Exp Immunol. 2004; 138(1):139-44. PMC: 1809193. DOI: 10.1111/j.1365-2249.2004.02609.x. View

Brandt L, Skeiky Y, Alderson M, Lobet Y, Dalemans W, Turner O . The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs. Infect Immun. 2004; 72(11):6622-32. PMC: 523007. DOI: 10.1128/IAI.72.11.6622-6632.2004. View

Miyata M, Mitsuyama M, Ogata N, Nomoto K, Takeya K . Two steps in the generation of acquired cellular resistance against Listeria monocytogenes: accumulation and activation of macrophages. Immunology. 1982; 47(2):247-53. PMC: 1555438. View

Torres B, Johnson H . Lipopolysaccharide and polyribonucleotide activation of macrophages: implications for a natural triggering signal in tumor cell killing. Biochem Biophys Res Commun. 1985; 131(1):395-401. DOI: 10.1016/0006-291x(85)91815-7. View

Koga T, Mitsuyama M, Watanabe Y, Yamada A, Yoshikai Y, Nomoto K . Effect of increase in macrophage Ia expression on subsequent immune response in vivo. J Clin Lab Immunol. 1986; 20(1):29-35. View

von Reyn C, Clements C, Mann J . Human immunodeficiency virus infection and routine childhood immunisation. Lancet. 1987; 2(8560):669-72. DOI: 10.1016/s0140-6736(87)92451-2. View

Ding A, Nathan C, Stuehr D . Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol. 1988; 141(7):2407-12. View

Kindler V, Sappino A, Grau G, Piguet P, Vassalli P . The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell. 1989; 56(5):731-40. DOI: 10.1016/0092-8674(89)90676-4. View

Dannenberg Jr A . Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol Today. 1991; 12(7):228-33. DOI: 10.1016/0167-5699(91)90035-R. View

10.

Braun M, Cauthen G . Relationship of the human immunodeficiency virus epidemic to pediatric tuberculosis and Bacillus Calmette-Guérin immunization. Pediatr Infect Dis J. 1992; 11(3):220-7. DOI: 10.1097/00006454-199203000-00010. View

11.

de Waal Malefyt R, Yssel H, Roncarolo M, Spits H, De Vries J . Interleukin-10. Curr Opin Immunol. 1992; 4(3):314-20. DOI: 10.1016/0952-7915(92)90082-p. View

12.

Weltman A, Rose D . The safety of Bacille Calmette-Guérin vaccination in HIV infection and AIDS. AIDS. 1993; 7(2):149-57. DOI: 10.1097/00002030-199302000-00001. View

13.

Mulsch A, Mordvintcev P, Hauschildt S, Busse R . Diethyldithiocarbamate inhibits induction of macrophage NO synthase. FEBS Lett. 1993; 321(2-3):215-8. DOI: 10.1016/0014-5793(93)80111-7. View

14.

Orme I, Andersen P, Boom W . T cell response to Mycobacterium tuberculosis. J Infect Dis. 1993; 167(6):1481-97. DOI: 10.1093/infdis/167.6.1481. View

15.

DAndrea A, Valiante N, Ma X, Kubin M, Trinchieri G . Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med. 1993; 178(3):1041-8. PMC: 2191152. DOI: 10.1084/jem.178.3.1041. View

16.

Cooper A, Dalton D, Stewart T, Griffin J, Russell D, Orme I . Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med. 1993; 178(6):2243-7. PMC: 2191280. DOI: 10.1084/jem.178.6.2243. View

17.

Flynn J, Chan J, Triebold K, Dalton D, Stewart T, Bloom B . An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med. 1993; 178(6):2249-54. PMC: 2191274. DOI: 10.1084/jem.178.6.2249. View

18.

Colditz G, Brewer T, Berkey C, Wilson M, Burdick E, Fineberg H . Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA. 1994; 271(9):698-702. View

19.

Saha B, Das G, Vohra H, Ganguly N, Mishra G . Macrophage-T cell interaction in experimental mycobacterial infection. Selective regulation of co-stimulatory molecules on Mycobacterium-infected macrophages and its implication in the suppression of cell-mediated immune response. Eur J Immunol. 1994; 24(11):2618-24. DOI: 10.1002/eji.1830241108. View

20.

Trinchieri G . Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood. 1994; 84(12):4008-27. View